H. Satoh, L-CGM Study Group, T. Ohira, C. Moriya, I. Inoue, S. Kuribayashi, H. Seino, H. Hirai, T. Hiyoshi, H. Watada. Effects of linagliptin vs. voglibose on daily glucose excursions during continuous glucose monitoring of Japanese type 2 diabetes patients (L-CGM): A randomized, open-label, two-arm, parallel comparative trial. Diabetes and Metabolism. 2017. 43. 6. 550-553
Moriya C, Satoh H, Watada H. Febuxostat improves skeletal muscle insulin resistance via upregulating skeletal muscle PGC-1α expression in high fat diet fed male Wistar rats. Diabetologia. 2017. 60. Suppl. 1. S219-S219
Moriya C, Satoh H, Watada H. Febuxostat improves skeletal muscle insulin resistance via upregulating skeletal muscle PGC-1α expression in high-fat diet-fed male Wistar rats. Diabetes. 2017. 66. Suppl. 1. A524-A524
Moriya C, Satoh H. Teneligliptin decreases the uric acids levels by reducing xanthine dehydrogenase expression in White adipose tissue of the male Wister rats. Diabetologia. 2016. 59. Suppl. 1. S271 (568)
Hiroaki Satoh, Tetsuya Ohira, Chihiro Moriya, Ikuo Inoue, Shinichi Kuribayashi, Hiroaki Seino, Hiroyuki Hirai, Toru Hiyoshi, Hirotaka Watada. Effects of Linagliptin on Daily Glucose Excursion in Continuous Glucose Monitoring of Japanese Type 2 Diabetic Patients (L-CGM Study). DIABETES. 2017. 66. A315-A316
ホルモンと臨床.62 (3): 241-244, 2014
Febuxostat improves skeletal muscle insulin resistance in high fat diet fed male Wistar rats and also increases phosphorilation of AKT and AMPK in c2c12 muscle cells.
(78th American Diabetes Association Scientific Sessions. 2018)